Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2010 | 1 |
2019 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol. 2019 Jul;154(1):83-88. doi: 10.1016/j.ygyno.2019.04.012. Epub 2019 Apr 24.
Gynecol Oncol. 2019.
PMID: 31029508
Clinical Trial.
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
Gagno S, Poletto E, Bartoletti M, Quartuccio L, Romualdi C, Garziera M, Scalone S, Sorio R, Dreussi E, Zanusso C, De Mattia E, Roncato R, Cecchin E, Giorda G, De Vita S, Dal Bo M, Puglisi F, Toffoli G.
Gagno S, et al.
Gynecol Oncol. 2020 Jan;156(1):233-242. doi: 10.1016/j.ygyno.2019.10.019. Epub 2019 Nov 9.
Gynecol Oncol. 2020.
PMID: 31711657
Item in Clipboard
A phase II study of liposomal doxorubicin in recurrent epithelial ovarian carcinoma.
Arcuri C, Sorio R, Tognon G, Gambino A, Scalone S, Lucenti A, Caffo O, Valduga F, Arisi E, Galligioni E.
Arcuri C, et al.
Tumori. 2004 Nov-Dec;90(6):556-61. doi: 10.1177/030089160409000604.
Tumori. 2004.
PMID: 15762356
Clinical Trial.
Item in Clipboard
Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.
Murgia V, Sorio R, Griso C, Caffo O, Arcuri C, Ferro A, Caldara A, Scalone S, Arisi E, Galligioni E.
Murgia V, et al.
Int J Gynecol Cancer. 2010 Aug;20(6):953-7. doi: 10.1111/IGC.0b013e3181e4a6c1.
Int J Gynecol Cancer. 2010.
PMID: 20683401
Clinical Trial.
Item in Clipboard
Cite
Cite